Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 4, 2012, Pages 1024-1030

  Diot, Quentin ^a   Kavanagh, Brian ^a   Schefter, Tracey ^a   Gaspar, Laurie ^a   Stuhr, Kelly ^a   Miften, Moyed ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Computed tomography; Density changes; Fibrosis; Lung cancer; Stereotactic body radiation therapy

Indexed keywords

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; PATIENT MONITORING; RADIOTHERAPY; TISSUE; TOMOGRAPHY; TUMORS;

COMPUTED TOMOGRAPHY SCAN; DENSITY CHANGE; DOSE-RESPONSE CURVES; FIBROSIS; FOLLOW-UP INTERVALS; LUNG CANCER; METHODS AND MATERIALS; STEREOTACTIC BODY RADIATION THERAPY;

PATIENT TREATMENT;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DENSITY; FEMALE; FOLLOW UP; HUMAN; LUNG PARENCHYMA; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME; ADULT; AGED; LUNG; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; RADIOGRAPHY; RADIOSURGERY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOSURGERY; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84872034205     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.11.080     Document Type: Article

References (34)

1. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005; 63: 1427-1431.
2. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metas-tases. J Clin Oncol 2009; 27: 1579-1584.
3. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-4839.
4. Xia TY, Li HQ, Sun QX, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006; 66: 117-125.
5. Gross N. Pulmonary effects of radiation therapy. Ann Intern Med 1977; 86: 81-92.
6. Movsas B, Raffin TA, Epstein AH, et al. Pulmonary radiation injury. Chest 1997; 111: 1061-1076.
7. Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose-volume effect in the lung. Int J Radiat Oncol Biol Phys 2010; 76(Suppl): S70-S76.
8. Yamashita H, Nakagawa K, Nakamura N, et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2007; 2: 11.
9. Wong JW, Sharpe MB, Jaffray DA, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 1999; 44: 911-919.
10. Thirion JP. Image matching as a diffusion process: An analogy with Maxwell's demons. Med Image Anal 1998; 2: 243-260.
11. Deasy JO, Blanco AI, Clark VH. CERR: A computational environment for radiotherapy research. Med Phys 2003; 30: 979-985.
12. Woel RT, Munley MT, Hollis D, et al. The time course of radiation therapy-induced reductions in regional perfusion: A prospective study with >5 years of follow-up. Int J Radiat Oncol Biol Phys 2002; 52: 58-67.
13. Fan M, Marks LB, Lind P, et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys 2001; 51: 311-317.
14. Astrahan M. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation. Med Phys 2008; 35: 4161-4172.
15. Fowler JF. Linear quadratics is alive and well: In response to Park et al. (Int J Radiat Oncol Biol Phys 2008; 70: 847-852)
16. [Letter]. Int J Radiat Oncol Biol Phys 2008; 72. 957-957.
17. Kavanagh BD, Newman F. Toward a unified survival curve: In response to Park et al. (Int J Radiat Oncol Biol Phys 2008; 70: 847-852)
18. and Krueger et al. (Int J Radiat Oncol Biol Phys 2007; 69: 1262-1271)
19. [Letter]. Int J Radiat Oncol Biol Phys 2008; 71: 958-959.
20. Ma J, Zhang J, Zhou S, et al. Regional lung density changes after radiation therapy for tumors in and around thorax. Int J Radiat Oncol Biol Phys 2010; 76: 116-122.
21. Theuws JCM, Seppenwoolde Y, Kwa SLS, et al. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys 2000; 47: 1201-1208.
22. Skoczylas JZ, Bentzen SM, Overgaard M, et al. Time course of radiological lung density changes after postmastectomy radiotherapy. Acta Oncologica 2000; 39: 181-187.
23. Kahán Z, Csenki M, Varga Z, et al. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007; 68: 673-681.
24. Palma DA, van Sörnsen de Koste J, Verbakel WFAR, et al. Lung density changes after stereotactic radiotherapy: A quantitative analysis in 50 patients. Int J Radiat Oncol Biol Phys 2011; 81: 974-978.
25. Brock KK. Results of a multi-institution deformable registration accuracy study (MIDRAS). Int J Radiat Oncol Biol Phys 2010; 76: 583-596.
26. Gu SC, Wilson D, Tan J, et al. Pulmonary nodule registration: Rigid or nonrigid? Med Phys 2011; 38: 4406-4414.
27. McDonald S, Rubin P, Phillips TL, et al. Injury to the lung from cancer-therapy: Clinical syndromes, measurable end-points, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995; 31: 1187-1203.
28. Takeda T, Takeda A, Kunieda E, et al. Radiation injury after hypo-fractionated stereotactic radiotherapy for peripheral small lung tumors: Serial changes on CT. Am J Roentgenol 2004; 182: 1123-1128.
29. Kyas I, Hof H, Debus J, et al. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007; 67: 768-774.
30. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45: 323-329.
31. Gayou O, Parda DS, Miften M. EUCLID: An outcome analysis tool for high-dimensional clinical studies. Phys Med Biol 2007; 52: 1705-1719.
32. Novakova-Jiresova A, van Luijk P, van Goor H, et al. Changes in expression of injury after irradiation of increasing volumes in rat lung. Int J Radiat Oncol Biol Phys 2007; 67: 1510-1518.
33. Chen Y, Williams J, Ding I, et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 2002; 12: 26-33.
34. Ghobadi G, Hogeweg LE, Faber H, et al. Quantifying local radiation-induced lung damage from computed tomography. Int J Radiat Oncol Biol Phys 2010; 76: 548-556.